Novartis Meningococcal ACWY Conjugate Vaccine

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines

Conditions

Human Papillomavirus InfectionMeningococcal DiseaseMeningococcal MeningitisPertussisTetanus

Phase 3

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

CompletedNCT00518180

Novartis VaccinesHuman Papillomavirus Infection, Meningococcal Meningitis, Pertussis +1

Start: 2007-07-31End: 2008-10-31Updated: 2016-05-18

Unknown Phase

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older

WithdrawnNCT01705379

Novartis VaccinesMeningococcal Disease

Start: 2013-03-31End: 2016-04-30Updated: 2016-12-01